logo

For the Inventor, By the Inventor

Shinjuku-ku, Japan

Toyama Chemical Co., Ltd.


USPTO Granted Patents = 159



Forward Citations = 1,053

Loading Chart...
Loading Chart...

278 inventors (with patents filed for the assignee):

goldMedal Isamu Saikawa (48 out of 49 patents)

silverMedal Shuntaro Takano (27 out of 27 patents)

bronzeMedal Hirokazu Narita (23 out of 24 patents)

4.  Takashi Yasuda (22 out of 22 patents)

5.  Satoshi Ono (21 out of 21 patents)

6.  Kaishu Momonoi (18 out of 18 patents)

7.  Chosaku Yoshida (17 out of 17 patents)

8.  Hiroyuki Imaizumi (16 out of 17 patents)

9.  Yutaka Kodama (16 out of 16 patents)

10.  Takihiro Inaba (14 out of 15 patents)

11.  Takako Hori (13 out of 13 patents)

12.  Mutsuko Maekawa (12 out of 12 patents)

13.  Shohachi Murakami (12 out of 12 patents)

14.  Hisatsugu Tsuda (12 out of 12 patents)

15.  Hiroshi Sakai (11 out of 72 patents)


Core Competencies:
Hydroxamic Acid Derivative
Antibacterial Composition
Cerebral Amyloid Beta
Autoimmune Diseases
Alkyl Ether Derivative
Neurogenesis Inducer
Antifungal Agent
Pyrazine Derivative
Nerve Injury Rehabilitation
Protein Kinase C Activity
Heterocyclic Compound
Retinal Nerve Diseases

159 patents:

1. 10149911 - Pharmaceutical composition containing hydroxamic acid derivative or salt thereof (2018-12-11),
2. 10123990 - Method for using novel hydroxamic acid derivative and antibacterial substance in combination (2018-11-13),
3. 10098879 - Methods and pharmaceutical compositions for the treatment of ebola virus disease (2018-10-16),
4. 10039744 - Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof (2018-08-07),
5. 9968585 - Prevention or treatment agent for cerebral amyloid beta storage diseases (2018-05-15),
6. 9918963 - Therapeutic agent for disease based on inhibitory effect of macrophage migration inhibitory factor (2018-03-20),
7. 9872914 - Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof (2018-01-23),
8. 9862676 - Hydroxamic acid derivative or salt thereof (2018-01-09),
9. 9624215 - Amine derivative or salt thereof (2017-04-18),
10. 9499477 - Hydroxamic acid derivative (2016-11-22),
11. 9421186 - Method for improving therapy for autoimmune diseases such as rheumatoid arthritis (2016-08-23),
12. 9096547 - Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide (2015-08-04),
13. 9090571 - Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide (2015-07-28),
14. 9073821 - Hydroxamic acid derivative (2015-07-07),
15. 9066977 - Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components (2015-06-30),
Toyama Chemical Co., Ltd. is a renowned pharmaceutical company based in Japan. With a focus on research, development, and manufacturing of innovative medicines, the company aims to contribute to the advancement of healthcare globally. Toyama Chemical is committed to delivering high-quality pharmaceutical products and improving the lives of patients worldwide. For more information about their products and services, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

159 Patents

#1 in Shinjuku-ku

#801 in Japan

#5,050 in the World

...
Shinjuku-ku, Japan

Toyama Chemical Co., Ltd.

Forward Citations = 1,053

278 inventors:

goldMedal Isamu Saikawa (48 out of 49 patents)

silverMedal Shuntaro Takano (27 out of 27 patents)

bronzeMedal Hirokazu Narita (23 out of 24 patents)

4.  Takashi Yasuda (22 out of 22 patents)

5.  Satoshi Ono (21 out of 21 patents)

Please report any incorrect information to support@idiyas.com
Loading…